Brief: Todos Medical Enters Into Binding Agreement To Acquire All 3Cl Protease Biology-Related Assets And Intellectual Property From NLC Pharma
Nov 30 (Reuters) - Todos Medical Ltd TOMDF.PK :
* TODOS MEDICAL ENTERS INTO BINDING AGREEMENT TO ACQUIRE ALL
3CL
PROTEASE BIOLOGY-RELATED ASSETS AND INTELLECTUAL PROPERTY FROM
NLC PHARMA
* TODOS MEDICAL LTD - TO FORM MAJORITY OWNED SUBSIDIARY,
3CL
SCIENCES, AN ENTITY FOCUSED ON DEVELOPMENT OF VARIANT-AGNOSTIC
COVID-19 ANTIVIRALS
* TODOS MEDICAL LTD - SHALL ALSO COMMIT ITS EFFORTS TOWARD
FACILITATING "GO PUBLIC" TRANSACTION FOR 3CL SCIENCES WITHIN 9
MONTHS OF CLOSING OF DEAL
Source text for Eikon: GNXblGhwZ
Further company coverage: TOMDF.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Todos Medical
See all newsBrief: Todos Medical Enters Into Exclusive Worldwide Automated Retail Supply Agreement With Smart Automated Retail Network
Brief: Todos Medical Clia/Cap Lab Provista Submits Emergency Use Authorization Application For Monkeypox Pcr Test To Us FDA
Brief: Todos Medical Provides Corporate Update
Brief: Todos Medical Enters Into $50 Mln Contract To Supply Tollovid, CBD Products To Retail Distributor Company Nerd Hemp
Brief: Todos Medical Establishes Botanical Supplement Manufacturing Capabilities